“showed a trend”

While male gender showed a trend towards a negative association with PF scores (β = −0.393, p = 0.084), this association did not reach statistical significance. 4.

Compared to the LSTG group, the HSTG group showed a trend toward increased levels of taurine (Tau, P = 0.084) and Cit ( P = 0.064), but no significant changes in other amino acids were observed ( P > 0.05).

Similarly, participants with PDL1-null tumors showed a trend toward longer OS in the SBRT arm compared with the control arm (median OS: 7.21 versus 6.05 months; log-rank test, P = 0.084) (Extended Data Fig. 8b ).

Additionally, CV mortality showed a trend of increase across risk groups (Fig. 3 B, log-rank p = 0.084), with 3-year cumulative incidences of 1.4% in the low-risk group, 5.1% in the medium-risk group, and 11.8% in the combined-high-risk group.

In paired biopsies, on-treatment increase in iTIL showed a trend toward improved PFS (HR 0.64, 95% CI 0.40 to 1.06, p=0.084) and was significantly associated with improved OS (HR 0.55, 95% CI 0.35 to 1.01, p=0.037).

Although non-significant, the combination treatment showed a trend of improved DFS compared to the no-treatment control ( p = 0.084) ( Figure 5 B).

However, after the first 48 h of admission, patients with a greater diuretic response on admission (NaU > 80 mmol/L) showed a trend of having fewer pulmonary b-lines (12 vs. 15; p = 0.084), a lower IVC diameter (18 mm vs. 22 mm; p = 0.009), and lower IAP values (11 mmHg vs. 13 mmHg; p = 0.041).

Both high burden of cerebellar intracortical lesions and brain WML showed a trend to predict SDMT score (β = −7.869, 95% CI −16.843 to 1.106, p = 0.084, and β = −7.837, 95% CI −16.371 to 0.698, p = 0.071, respectively).

In the matched cohort, similar to the total cohort, the interaction term for age (per 10-year increment) × SNA showed a trend toward statistical significance but did not reach it (HR 0.81, 95% CI [0.63–1.04], p = 0.084).

5 f, elevated S100A2 was significantly associated with worse OS in SCLC patients ( P = 0.04) and showed a trend towards worse PFS ( P = 0.084).

The results showed a trend of significant consistency between these two data sets ( P = 0.084).

A baseline CAT score ≥10 was a significant predictor of acute exacerbations, and although not reaching statistical significance, an improvement in SGRQ score at 6 months showed a trend toward being protective against an increased frequency of exacerbations (p=0.084).

Although the difference did not reach statistical significance after multiple comparison adjustment, the PROP-tPA/8 h group showed a trend toward lower IL-6 levels compared with the LPS group (adjusted P = 0.084).

Male sex showed a trend toward lower mortality (OR = 0.91, 95% CI: 0.81–1.01, p = 0.084).

Age-stratified PERMANOVA within the same timepoint comparisons confirmed this pattern: in 1–2-year-olds, Ill and Not-Ill children showed a trend toward divergence at D15 ( F (1, 178) = 2.32, p = 0.084, R 2 = 0.013, 95% CI [0.008, 0.030]) and significant separation at D85 ( F (1, 194) = 2.64, p = 0.049, R 2 = 0.013, 95% CI [0.008, 0.031]), whereas no significant separation was observed in the 7–12-month or >2-year groups at any timepoint (Fig. 2 ; Supplementary Table 9 ).

HIV+ mice showed a trend towards higher human (P = 0.084 and 0.096) and murine TNF-alpha levels (*, P = 0.045 and P = 0.11 for DSS− and DSS+ mice).

Furthermore, in 489 cases, a decreased EpCAM expression showed a trend towards the presence of distant metastasis ( P =0.084).

Scapholunate angle Immediately postreconstruction (Stage 4), MBT showed a trend toward a higher SL angle than RASL ( P = .084).

Change from baseline in MADRS total score with olanzapine was not statistically different from placebo at day 7 (-5.3 ± 0.9 vs -3.6 ± 1.4; P = 0.314), but it showed a trend towards statistical significance on day 21 (-8.8 ± 1.0 vs -5.4 ± 1.6; P = 0.084) (Figure 1B ).

Unexpectedly, our study did not find a significant correlation between tumour stage and Cathepsin D expression but it showed a trend ( p = 0.084).

In the remote zone, the empagliflozin group showed a trend toward increased total NO levels compared with the control‐MI ( P =0.084) and empagliflozin+sacubitril/valsartan groups ( P =0.059).

Post-hoc analysis using CMPA+ SPT and CMPA+ susp showed a trend in the ITT analysis toward a preventive effect of pHF as compared to SF [CMPA+ SPT : 4.2 vs. 9.2%, RR 0.45 (0.18, 1.12), p = 0.084, CMPA+ susp : 4.9 vs. 10.5%, RR 0.46 (0.20, 1.11), p = 0.067].

Results showed a trend toward an interaction between injection treatment and cooking time ( p = 0.084) on metallic flavour development in cooked meat.

Children with typical CK-AML showed a trend for decreased OS (5-year OS: 0 vs. 33 ± 12.7%.; p = 0.084) but no difference in EFS (5-year EFS: 0 vs. 33.0 ± 12.7%; p = 0.14) compared with those with atypical CK-AML.

Furthermore, ccRCC patients with high CD163+ TAMs showed a trend of advanced UICC-stage (OR 4.55, 95% CI 1.65–12.57, I 2 = 0.0%, p = 0.084) while CD68+ TAMs did not (OR: 2.80, 95% CI 0.88–8.96, I 2 = 69.8%, p = 0.036) ( Figure 3E ).